We look at some recent studies that use organ-on-a-chip models to provide insights into human biology and drug.

The FDA is favoring newer testing and modeling methods that reduce animal testing, research costs, and evaluation time.

The Food and Drug Administration's decision to phase out animal testing in drug development is being hailed as a potential ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu.

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...

Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...